Overview
Hypogonadism-mitral valve prolapse-intellectual disability syndrome (also known as Gorlin-Chaudhry-Moss syndrome or GCM syndrome) is an extremely rare genetic disorder characterized by a distinctive combination of features affecting multiple body systems. The syndrome was first described in the medical literature and involves the endocrine, cardiovascular, and central nervous systems as its primary areas of involvement. Key clinical features include hypogonadism (underdevelopment of the reproductive organs with reduced production of sex hormones), mitral valve prolapse (a cardiac valve abnormality where the mitral valve does not close properly), and intellectual disability of variable severity. Additional features that have been reported in affected individuals include craniofacial anomalies such as craniosynostosis, midface hypoplasia, hypertrichosis (excessive hair growth), dental anomalies, and eye abnormalities including microphthalmia or other ocular defects. Short stature and hearing loss have also been described in some patients. The condition is present from birth, though some features such as hypogonadism may become more apparent during puberty when expected sexual development fails to occur normally. The cardiac involvement, specifically mitral valve prolapse, requires monitoring and may necessitate cardiology follow-up. There is no specific cure for this syndrome, and management is supportive and symptomatic. Treatment typically involves a multidisciplinary approach including hormone replacement therapy for hypogonadism, cardiac monitoring and management for mitral valve prolapse, special education support for intellectual disability, and surgical interventions as needed for craniofacial or other structural anomalies. Genetic counseling is recommended for affected families.
Also known as:
Clinical phenotype terms— hover any for plain English:
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Hypogonadism-mitral valve prolapse-intellectual disability syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Hypogonadism-mitral valve prolapse-intellectual disability syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Hypogonadism-mitral valve prolapse-intellectual disability syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Hypogonadism-mitral valve prolapse-intellectual disability syndrome.
Community
No community posts yet. Be the first to share your experience with Hypogonadism-mitral valve prolapse-intellectual disability syndrome.
Start the conversation →Latest news about Hypogonadism-mitral valve prolapse-intellectual disability syndrome
No recent news articles for Hypogonadism-mitral valve prolapse-intellectual disability syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Hypogonadism-mitral valve prolapse-intellectual disability syndrome
What is Hypogonadism-mitral valve prolapse-intellectual disability syndrome?
Hypogonadism-mitral valve prolapse-intellectual disability syndrome (also known as Gorlin-Chaudhry-Moss syndrome or GCM syndrome) is an extremely rare genetic disorder characterized by a distinctive combination of features affecting multiple body systems. The syndrome was first described in the medical literature and involves the endocrine, cardiovascular, and central nervous systems as its primary areas of involvement. Key clinical features include hypogonadism (underdevelopment of the reproductive organs with reduced production of sex hormones), mitral valve prolapse (a cardiac valve abnorma
How is Hypogonadism-mitral valve prolapse-intellectual disability syndrome inherited?
Hypogonadism-mitral valve prolapse-intellectual disability syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Hypogonadism-mitral valve prolapse-intellectual disability syndrome typically begin?
Typical onset of Hypogonadism-mitral valve prolapse-intellectual disability syndrome is neonatal. Age of onset can vary across affected individuals.